Pamidronate lines.
dc.contributor.author | Srinivasan, Ramesh | en_US |
dc.date.accessioned | 2005-09-07 | en_US |
dc.date.accessioned | 2009-05-27T05:21:27Z | |
dc.date.available | 2005-09-07 | en_US |
dc.date.available | 2009-05-27T05:21:27Z | |
dc.date.issued | 2005-09-07 | en_US |
dc.identifier.citation | Srinivasan R. Pamidronate lines. Indian Pediatrics. 2005 Sep; 42(9): 959-60 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/10267 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Antineoplastic Agents --adverse effects | en_US |
dc.subject.mesh | Bone Density --drug effects | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Diphosphonates --adverse effects | en_US |
dc.subject.mesh | Femur --drug effects | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Osteogenesis Imperfecta --drug therapy | en_US |
dc.title | Pamidronate lines. | en_US |
dc.type | Case Reports | en_US |
dc.type | Letter | en_US |
Files
License bundle
1 - 1 of 1